[1] POURNARAS S，MANIATI M，PETINAKI E，et al.Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4[J ] . J Antimicrob Chemother，2003，51(6)： 1409-1414. [2] DODDAREDDY M R，CHA J H，CHO Y S，et al. Volsurf analysis of carbapenem antibiotics[J] . Bioorg Med Chem，2005，13 (10)： 3339-3349. [3] CHUKWUEMEKA S，OKEREK E. Advance in the use of carbapenem antibiotics in the management of serious bacterial infectious in special patient populations. I： safety and efficacy in children and elderly patients[J] . Curr Ther Res Clin Exp，2000，61(5)： 289-320. [4] OH C H，LEE S C，CHO J H，Synthesis and antibacterial activity of 1β-methyl -2- [5- (N - substituted-2-hydroxy iminoethyl)pyrrolidin-3-ylthio] carbapenem derivatives[J] . Eur J Med Chem，2003，38(7-8)： 751-758. [5] LEE J S，CHOA J H，CHO H，et al. Synthesis and antibacterial evaluation of 1β -methyl -2-(5 -substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives[J] . Arch Pharm (Weinheim)，2004，337(7)： 391-397. [6] CHO H W，OH C H，LEE J S，et al. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems： containing heteroaromatics as a side chain[J] . Arch Pharm (Weinheim)，2003，336(11)： 495-503. [7] OH C H，CHO J H. Synthesis and biological evaluation of 1β-methyl carbapenems having guanidino moieties[J] . Eur J Med Chem，2006，41(1)： 50-55. [8] LEVINE D P，FROMM B S，REDDY B R. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis[J] . Ann Intern Med，1991，115(9)： 674-680. [9] NAGANO R，SHIBATA K，DACHI Y，et al. In vitro activities of novel trans-3，5-disubstituted pyrrolidinylthio-1β-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa[J] . Antimicrob Agents Chemother，2000，44(3)： 489-495. [10] IMAMURA H，OHTAKE N，SHIMIZU A. et al. Structure-activity relationships of trans-3，5- disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1： J-111，347 and related compounds [J] . Bioorg Med Chem Lett，2000，10(2)： 109-113. [11] SUMITA Y，NOUDA H，KANAZAWA K，et al. Antimicrobial activity of SM-17466，a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus[J] . Antimicrob Agents Chemother，1995，39(4)： 910-916. [12] UEDA Y，SUNAGAWA M. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio) -1β - methylcarbapenems with potent activities against multiresistant Gram-positive bacteria[J] . Antimicrob Agents Chemother，2003，47(8)： 2471-2480. [13] UEDA Y，ITOH M，SASAKI A，et al. SM-216601，a novel parenteral 1beta-methylcarbapenem： structure-activity relationships of antibacterial activity and neurotoxicity in mice[J] . J Antibiot (Tokyo)，2005，58(2)： 118-140. [14] UEDA Y，KANAZAWA K，EQUCHI K. et al. In vitro and In Vivo antibacterial activities of SM-216601，a new broad-spectrum parenteral carbapenem[J] . Antimicrob Agents Chemother，2005，49(10)： 4185-4196. [15] SUNAGAWA M，ITOH M，KUBOTA K. et al. New anti-MRSA and anti-VRE carbapenems： synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio) carbapenems[J] . J Antibiot (Tokyo)，2002，55(8)： 722-757. [16] WEISS W J，PETERSEN P J，JACOBUS N V. et al. In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems[J] . Antimicrob Agents Chemother，1999，43(3)： 454-459. [17] JIRASKOVA N . THF carbapenems. Wyeth Ayers[J] . Curr Opin Investig Drugs，2001，2(8)： 1035-1038. [18] NORRBY S R. Neurotoxicity of carbapenem antibiotics：consequences for their use in bacterial meningitis[J] . Antimicrob Agents Chemother，2000，45(1)： 5-7. [19] JIN C，JUNG I，KU H J，et al. Low convulsive activity of a new carbapenem antibiotic，DK-35C，as compared with existing congeners[J] . Toxicology，1999，138(2)： 59-67. [20] HORIUCHI M，KIGUMI M，TOKUMUR A. et al. Absence of convulsive liability of doripenem，a new carbapenem antibiotic，in comparison with β-lactam antibiotics[J] . Toxicology，2006，222(1-2)： 114-124.